Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
Neurophet AQUA
2022

Share:

Neurophet AQUA

Medical diagnostic solution

NEUROPHET, Inc.

NEUROPHET AQUA is a medical AI solution for the diagnosis of dementia. AQUA helps doctors detect structural changes in the brain early before dementia occurs. This allows patients to receive appropriate treatment at the right time. Through AI algorithms, AQUA can detect quantitative changes in the brain that cannot be visually grasped from an MRI. Most medical solutions are slow, difficult, and complex. However, AQUA simplified and automated all these processes, greatly reducing the time users spend on analysis. AQUA helps medical staff diagnose dementia more efficiently so they can provide care to patients.

Date of Launch
2021
Development Time
13 - 24 months
Target Regions
Asia, Europe, North America
Target Groups
Consumer / User, Trade / Industry, Specific sub-group: Doctor, Medical staff, Senior patients

RELATED PROJECTS